- If you are wondering whether Abbott Laboratories at around US$101.56 is offering value or just noise, it helps to step back and look at the full picture on price versus fundamentals.
- The stock is down 1.9% over the last week, 7.6% over the last month, and 20.1% over the past year, which may lead some investors to reassess both its growth potential and perceived risk.
- Recent headlines around Abbott have focused on its ongoing role in the medical devices and diagnostics space, with attention on how its product portfolio positions it within the broader healthcare sector. This context has kept investor interest alive even as the share price has moved lower over multiple time frames.
- Right now, Abbott holds a valuation score of 5 out of 6,…
Bitget confirms $351.6M crypto hack and suspends withdrawals
September 25, 2026
